This week, Hims & Hers’ (NYSE:HIMS) recent Super Bowl ad campaign was at least twice mentioned by Marty Makary, Commissioner of the U.S. Food and Drug Administration (FDA) as a glaring example of how drugmakers breach U.S. regulations related to direct-to-consumer advertising.